Nano4 Global

Fast and affordable colorimetric precision nanodiagnostics

Nano4 Global is a young start-up launched in 2015 to market innovative nanotechnology based molecular diagnostics.

Nano4 is pioneering a new high-confidence proprietary nanotechnology platform relying on more than 12 years of research and development at Universidade NOVA de Lisboa - Science and Technology, Department of Life Sciences.

Nano4 Industrial facility

Nano4 Global has a fully dedicated manufacturing lab. Located near Lisbon within a pharmaceutical campus hosting a Portuguese pharma company in Portugal. Nano4 Global manufacturing capability offer molecular diagnostic production and custom nanotechnology proficiency.

Nano4 Platform

How It Works

NANO4 Platform relies on a colorimetric molecular diagnostic method based on gold nanoparticles that provide fast and specific identification of a DNA or RNA biomarker.

NANO4 platform provides a colorimetric molecular diagnostic method based on gold nanoprobes that allow fast and specific identification of a DNA or RNA biomarker. The friendly use of Nano4 nanodiagnostics puts forward a fast, accurate, affordable technology - the next generation of molecular nanodiagnostics.

NANO4 is the next generation of molecular nanodiagnostics applied to life sciences that provides simple readout depending on the biomarker.
NANO4 is an award winning technology - Santander Totta/NOVAScientific Prize.


Gold nanoprobes provide a visual
colorimetric change to identify
the desired DNA/RNA sequence.

Advantages
  • fast colorimetric output
  • accurate
  • affordable and user friendly
       (no dedicated apparatus needed)

Turn Around Time


Due to the easy and simple operation, NANO4 will impact the way molecular diagnostics are performed and will lead the decentralization of molecular diagnostics - from genetics lab to point of need.


Visual Colorimetric Change
BLANK Gold nanoprobes provide a visual colorimetric change that identifies a DNA/RNA sequence.
POSITIVE Target DNA/RNA prevents aggregation. Solution remains RED after revelator.
NEGATIVE Gold nanoprobes aggregates in contact with a revelator. color changes RED to BLUE
BLANK
Gold nanoprobes provide a visual colorimetric change that identifies a DNA/RNA sequence.
POSITIVE
Target DNA/RNA prevents aggregation. Solution remains RED after revelator.
NEGATIVE
Gold nanoprobes aggregates in contact with a revelator. color changes RED to BLUE


More/ Published data

Pipeline

Diagnostic Focus

NANO4 platform is extremely flexible and easily adapted to a range of applications where specific DNA or RNA sequence is critical, such as detection of human pathogens (validation ongoing for M. tuberculosis, Zika), selected cancers and other genetic diseases.

R&D Design Development Clinical Validation
TB

Zika

Leukaemia

Undisclosed Prog.

Media

News & Updates
  March  2019
The 15 Biotech Companies in Portugal You Should Know
  May  2018
Nano4 awarded with grant from H2020 - SME Instrument Phase 2
  November  2016
NOS Inovação Awards 2016 - Nano4 selected as one of the 30 most innovative companies
  September  2016
Nano4 was selected as one of the 66 companies selected to represent Portugal in the Web Summit 2016
Awards and grants

Granted with SME phase 2 in 2018: 1,4 M€ grant

Granted with SME phase 1 in 2017

Granted with P2020 non-dilutive fund in 2018

Appointed as one of the 30 most innovative companies in Portugal at NOS Awards 2017

One of the 66 companies selected to the programme Road to Websummit 2016

Gold Nanoparticles Platform was recognized in 2012 with Santander Totta / Universidade Nova Lisboa awarded of technology

Contact Us

Nano4 Global, Lda
Estrada da Granja do Marquês,
nº 339, Armazém B
2710-142 Sintra

Email:
info@nano4global.com

Direction:
38°49'28.7"N 9°21'16.2"W

Follow us on

close